Orthogonal Chemistry Enables Precision Nanoparticle Cofunctionalization for Tuning Immune Stimulation and Antigen
Alexander J Heiler1,2, Claire A McClain1,3, Samuel N Lucas1,3
1Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Abstract:
Combination therapies are increasingly utilized to treat complex diseases, capitalizing on drug synergies to potentiate overall therapeutic responses and improve patient outcomes. Drug delivery systems improve combination therapy access to tissues and cells of interest, but attempting to coconjugate multiple drugs to the same carrier can limit the precision of drug ratios or release behaviors, making it challenging to optimize the delivery of the individual drug compounds. Here, thiol-disulfide exchange and strain-promoted click chemistry are leveraged in combination with an established polymeric nanoparticle platform to achieve chemistry-defined control over both the conjugation ratio and release behavior of coconjugated moieties. When applied as a subunit vaccine platform, this system enables the modulation of lymph node dendritic cell maturation and antigen presentation. The results presented here thus demonstrate a versatile dual-functional drug delivery platform to overcome existing challenges in combination therapy delivery.
Insights
This study introduces a novel dual-functional drug delivery platform for combination therapies. It precisely controls drug ratios and release, enhancing therapeutic outcomes and vaccine development.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery
Background:
- Combination therapies are crucial for complex diseases, but precise delivery of multiple drugs remains a challenge.
- Current methods for co-delivering drugs via nanoparticles struggle with controlling individual drug ratios and release kinetics.
- Optimizing drug ratios and release is essential for maximizing therapeutic synergy and patient outcomes.
Purpose of the Study:
- To develop a versatile drug delivery platform enabling chemistry-defined control over the conjugation ratio and release behavior of co-delivered drugs.
- To address limitations in current nanoparticle-based combination therapy delivery systems.
- To demonstrate the platform's utility in modulating immune responses as a subunit vaccine.
Main Methods:
- Utilizing thiol-disulfide exchange and strain-promoted click chemistry for controlled drug conjugation.
- Employing an established polymeric nanoparticle platform for drug encapsulation and delivery.
- Evaluating the platform's efficacy in modulating dendritic cell maturation and antigen presentation in lymph nodes.
Main Results:
- Achieved precise control over the conjugation ratio and release profiles of co-delivered therapeutic moieties.
- Demonstrated successful application of the platform as a subunit vaccine, modulating immune cell activity.
- Overcame key challenges associated with optimizing combination therapy delivery using a single carrier.
Conclusions:
- The developed dual-functional drug delivery platform offers a versatile solution for advanced combination therapies.
- Precise control over drug ratios and release enhances therapeutic potential and opens new avenues for vaccine design.
- This system represents a significant advancement in overcoming existing hurdles in multi-drug delivery systems.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
00:42Cross-reactivity